Andrew has more than three decades of experience in senior international commercial leadership positions within the Pharmaceuticals and Medical Devices sectors. With a specialization in early access pre-approval unlicensed medicines, he holds key responsibilities in leadership, commercial operations and financial performance. Andrew has had a significant contribution to facilitating medicine access throughout his tenure at Idis/Clinigen, Caligor, Inceptua, and is now Director of Early Access Programmes at Sciensus, Rare Diseases.
Andrew Cummins
Director of Expanded Access Programs
![Andrew Cummins](https://www.sciensus.com/wp-content/uploads/2024/05/Sciensus-Rare-Portraits-163-March-2024-by-Electric-Egg-Small-1-640x400.jpg)
Latest Articles by Expert
View the latest articles written by our expert